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Abstract
Altered performance monitoring has been demonstrated after administration of different pharmacological compounds and
in various clinical populations, such as excessive neurophysiological responses to mistakes in anxiety disorders. Here, a
novel social pharmacological approach was applied to investigate whether oxytocin administration (24 IU) enhances
performance monitoring for errors that have negative consequences for another individual, so-called social mistakes.
Healthy male volunteers (N¼24) participated in a placebo-controlled crossover design. EEG measures were obtained while
pairs of participants performed a speeded choice reaction-time task in an individual and social context. Following oxytocin
administration, error-related negativity amplitudes were increased for social compared with individual mistakes. This in-
crease was not found in the placebo condition. No effects of oxytocin were present in the individual context. The current
study shows that oxytocin enhances performance monitoring specifically for social mistakes. This outcome is in line with a
presumed role for oxytocin in salience attribution to social cues and underlines its context-dependency. Combining these
processes may thus open up new research avenues and advance our understanding of individual differences in perform-
ance monitoring and oxytocin responses from a social neurocognitive, pharmacological and clinical perspective.
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Introduction
Humans are usually quite efficient in detecting their errors and
generating adequate behavioral adjustments in response to
them. To accomplish this, people monitor their performance
continuously for errors and possible deviations from their goals
(de Bruijn et al., 2009). The cognitive and neural mechanisms of
performance monitoring have been studied extensively since
the discovery of an event-related potential (ERP) related to error
detection. This so-called error-related negativity (ERN) or error
negativity (Ne) is elicited immediately after an erroneous re-
sponse and is followed by positive deflections specific to error
trials collectively known as the error positivity (Pe; Falkenstein
et al., 1990; Gehring et al., 1993). The Pe consists of two subcom-
ponents: (i) the ‘early’ Pe that immediately follows the ERN and
shares the same neural generators and (ii) the ‘late’ Pe—also
referred to as the classical Pe –, which is a slow positive wave at
more parietal electrodes observed between 300 and 500 ms
post-response (Ullsperger et al., 2014b). The exact function of
the Pe is still under debate, but it is thought to be involved in
more conscious affective processing of the error (Ullsperger
et al., 2014a). Functional magnetic resonance imaging (fMRI)
studies have revealed a central role for an emotional and
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cognitive control network involving anterior cingulate cortex
and bilateral insular cortex, with increased activations in this
cingulate-insula network for erroneous compared with correct
actions (de Bruijn et al., 2009; Ridderinkhof et al., 2004). Here, we
employ a psychopharmacological approach to study the effects
of oxytocin administration on the electrophysiological correl-
ates of performance monitoring in a social context.
The ERN is assumed to trigger short-term behavioral adjust-
ments or long-term learning, and thus ensures efficient, safe and
flexible behavior (Falkenstein et al., 1990; Gehring et al., 1993).
However, the distress associated with making mistakes is usually
something we prefer to avoid, and the level of distress may also
be reflected in the neural response to errors. Hajcak et al. (2005),
for example, showed that ERN amplitudes were larger when an-
other person evaluated subjects’ performance online, inducing
increased error significance. This finding is in line with an abun-
dance of clinically oriented research showing that heightened
levels of trait anxiety are related to increased error-related activa-
tions (de Bruijn and Ullsperger, 2011), such as enhanced ERN
amplitudes in healthy volunteers with high levels of trait anxiety
(e.g. Aarts and Pourtois, 2010; Hajcak et al., 2003; Moser et al., 2013)
or in individuals suffering from obsessive–compulsive disorder
(OCD; e.g. Endrass et al., 2008, 2010; Endrass and Ullsperger, 2014;
Gehring et al., 2000; Stern et al., 2010).
Modulations of performance-monitoring processes may thus
be related to changes in affective distress associated with errors,
but the exact underlying mechanisms remain unclear. Errors
made in a social context are often even more upsetting as they
may be linked to increased responsibility for others or elicit feel-
ings of embarrassment. However, performance-monitoring re-
search has mainly focused on individual behavior and has only
more recently ventured into the domain of social performance
monitoring (e.g. de Bruijn et al., 2011; de Bruijn and von Rhein,
2012; Koban and Pourtois, 2014; Koban et al., 2012). This is surpris-
ing, because the social nature of human behavior implies that our
actions often also affect the people around us. Mistakes are of spe-
cific interest as they usually have negative consequences not only
for ourselves, but also for the persons around us.
Using fMRI, we previously showed that these so-called ‘social
mistakes’, i.e. errors that additionally affected a co-actor,
increased activations in mentalizing areas, such as dorsal medial
pre-frontal cortex (dMPFC; Radke et al., 2011). This finding supports
the notion that participants are thinking more about their co-
actor’s thoughts and feelings (Mitchell, 2009; Van Overwalle, 2011)
and take their perspective (Shamay-Tsoory et al., 2009a) when
their actions also have consequences for the other person com-
pared with when errors only affect themselves. Another study
showed that for errors that caused pain in others, fMRI revealed
increased activations in the (left) anterior insula (Koban et al.,
2013). Taken together, these fMRI studies suggest that increased
error significance associated with social mistakes may result in
enhanced activations in areas known to be involved in social cog-
nitive processes and performance monitoring. Importantly how-
ever, performance monitoring usually takes place within
milliseconds, and methods with a high temporal resolution such
as ERPs are thus more suited to capture the entire process.
Previous ERP studies have shown that activations of the
performance-monitoring network are highly susceptible to modu-
lations induced by psychopharmacological compounds and that
especially the neurotransmitter dopamine seems to play a crucial
role (see e.g. de Bruijn et al., 2004, 2006; Jocham and Ullsperger,
2009; Zirnheld et al., 2006). Interestingly, dopaminergic activity ap-
pears to be affected by the hormone oxytocin (Love, 2014) and a
recently proposed model highlights the overlap in performance-
monitoring structures targeted by oxytocin and dopamine, specif-
ically anterior cingulate, insula and striatum (Quattrocki and
Friston, 2014). From a social and therapeutic perspective, the role
of oxytocin in human behavior has been the topic of a growing
number of investigations over the past years. Oxytocin is a non-
apeptide synthesized in the hypothalamus and has been sug-
gested to facilitate prosocial behavior in healthy volunteers (e.g.
Domes et al., 2007; Heinrichs et al., 2009; Kosfeld et al., 2005) and
clinical populations (e.g. Yatawara et al., 2016; Guastella et al., 2015).
Indeed, initial studies mainly reported positive effects of
oxytocin administration on a wide range of socio-emotional
behaviors, e.g. improved trust or emotion recognition abilities
(see e.g. Kosfeld et al., 2005; but see Nave and McCullough, 2015;
Radke and de Bruijn, 2013). This view, however, has been chal-
lenged with recent studies emphasizing the context depend-
ency of such effects (see e.g. Bartz et al., 2011; Tabak et al., 2016).
In an attempt to explain the influence of context and personal-
ity characteristics as well as oxytocin-induced antisocial behav-
iors, such as envy and unfairness (see e.g. de Dreu et al., 2011;
Radke and de Bruijn, 2012; Shamay-Tsoory et al., 2009b),
Shamay-Tsoory and Abu-Akel (2016) have recently proposed
the social salience hypothesis of oxytocin. The central idea of
this framework is that the salience effect of oxytocin modulates
attention-orienting responses to external contextual social
cues, but is dependent on baseline individual differences such
as gender and personality traits. Importantly, Quattrocki and
Friston (2014) also point out that oxytocin receptor activation fa-
cilitates neuronal communication on several time scales, both
short-term and in a more enduring manner. This is important,
as oxytocin-induced modulations of immediate neural trans-
mission seem required for alterations of fast processes such as
attention-orienting and error detection. To the best of our
knowledge, no studies have yet investigated possible effects of
oxytocin on (social) performance monitoring.
Using a cross-over placebo-controlled design and a social
choice-reaction time task, we investigated whether oxytocin
modulates the electrophysiological correlates of social perform-
ance monitoring. In the placebo condition, we expected ERN
and Pe amplitudes to be enhanced for social compared with in-
dividual mistakes due to increased error significance. Following
the social salience hypothesis, the effect of social mistakes on




Healthy male volunteers (N¼ 24; mean age¼ 21.5 years;
SD¼ 1.9) performed two versions of a social flanker task. All par-
ticipants received financial compensation for participation.
None of the participants reported current or past neurological
or endocrine diseases, medication use, or drug or alcohol abuse,
and participants had to be between 18 and 30 years of age (see
Supplementary Material for further exclusion criteria). All par-
ticipants gave their written informed consent. Procedures were
in accordance with the Declaration of Helsinki and approved by
the Medical Ethics Committee of the University Medical Centre
in Nijmegen, the Netherlands.
Experimental procedure
We used a double-blind placebo-controlled within-subjects
design. Two participants—who did not know each other
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beforehand—were invited to come to the lab at the same time.
Upon arrival they self-administered six puffs (three per nostril)
resulting in a total of 24 intranasal units (IU) of placebo (a solu-
tion of sodium chloride or NaCl) or oxytocin (synthesized by
Defiante Farmaceutica, sigma-Tau, the Netherlands). An inde-
pendent research assistant who was blind to the experimental
hypotheses and who left immediately after administration
supervised the procedure. The experimenter was not present
during the administration. Randomization was performed and
controlled by the pharmacy of the University Medical Centre in
Nijmegen. The two experimental sessions were separated by
14 days scheduled for weekdays starting at 10 AM.
Following administration, preparations for EEG measure-
ments were taken and participants received written and verbal
task instructions. Participants were then seated next to one an-
other behind individual computer screens (see Figure 1) and
started task performance 40 min after substance administra-
tion. Throughout, participants wore earplugs to ensure that but-
ton clicks from the co-actors could not be heard. A screen was
placed between the participants so that they could not see the
buttons or computer screen of their co-actor.
Social flanker task
Participants performed a social version of the Flanker task
(Eriksen and Eriksen, 1974) in two different contexts (see
Figure 1). The goal of the Flanker task is to give a left or right
button press depending on the central letter (H or S) in a string
of five letters. The central letter can either be the same to the
surrounding (i.e. flanking) letters (congruent trial: e.g. HHHHH)
or different (incongruent trial: e.g. SSHSS). The two contexts (in-
dividual, social) were identical, except for the consequences of
errors. On top of the standard financial compensation, partici-
pants could win two additional money prizes. The winners
would be determined after completion of the entire study based
on their individual and joint performance, respectively. For the
individual prize, participants were split into two groups based
on their seating position, i.e. on the left or on the right. The best
performing participant of each group would win an additional
bonus meaning that members of a pair would never compete
against each other. For the joint prize, the best performing pair
of all pairs that participated would win. Ranking was based on a
combination of reaction times (RTs) and accuracy. Participants
were informed that the number of errors would be added to the
average RT and that the lowest scoring individual or pair would
be ranked highest. Importantly, this meant that in the individ-
ual context, any errors they made would only affect their own
chances of winning an additional bonus, while in the social con-
text errors would also negatively affect their co-actor’s chances
of winning additional money. Participants always performed
the tasks simultaneously and independently. Each context con-
sisted of 400 trials (50% congruent, 50% incongruent) and speed
and accuracy were equally emphasized in the general task in-
structions (see Supplementary Material for further task details).
Electrophysiological recordings and pre-processing
of the data
EEG data were recorded from both participants simultaneously
using 27 active electrodes per participant (ActiCap, Brain
Products, Munich, Germany) arranged according to an extended
version of the 10-20 system. Vertical eye movements were re-
corded by placing electrodes above and below the left eye and
horizontal eye movements were registered at the outer canthi
of the eyes. Electrophysiological data were acquired at 1000 Hz
without filtering with the QuickAmp amplifier (Brain Products)
and the electrodes were referenced to the left ear during signal
acquisition.
EEG data were further analyzed offline using Brain Vision
Analyzer 2.0 (Brain Products, Munich, Germany). All signals
were re-referenced to the average of the left and right mastoids.
All EEG signals were filtered with a band-pass filter between
.02 Hz and 20 Hz (24 dB/oct) and a notch filter of 50 Hz. Eye move-
ments were corrected using the Gratton, Coles and Donchin
method (Gratton et al., 1983) followed by artifact rejection.
Artifact rejection was done on the four electrodes of interest (Fz,
FCz, Cz and Pz) with the following settings: maximal allowed
voltage step: 50 mV/ms, maximal amplitude difference of 100 mV
in 200 ms intervals, minimal allowed amplitude: –50 mV, max-
imal allowed amplitude: 50 mV, lowest allowed activity in inter-
vals: 0.5 mV in 100 ms intervals. Response- and stimulus-locked
ERPs were baseline corrected relative to a 200 ms pre-response
or stimulus baseline. For both contexts and drug conditions,
epochs associated with correct and incorrect responses to in-
congruent stimuli were averaged separately and time-locked to
response onset, starting 200 ms before and ending 600 ms after
response onset. The ERN was determined on correct and error
trials in separate subject averages by subtracting the most nega-
tive peak in the 0–200 ms time window after response onset
from the most positive peak in the time window starting 80 ms
before and ending 80 ms after response onset at electrodes Fz,
FCz and Cz, covering the typical frontocentral distribution of the
ERN (Falkenstein et al., 1990; Gehring et al., 1993). The Pe is a
slowly developing ERP component with a more distributed top-
ography and known to consist of an early and a late component
(Ullsperger et al., 2014). Therefore, Pe amplitude was determined
on electrodes Fz, FCz, Cz and Pz on correct and error trials in sep-
arate subject averages in two ways: (i) the early Pe was defined
as the most positive peak in the 150–250 ms post-response time
window and (ii) the late Pe was determined as the mean ampli-
tude in the 300–500 ms post-response time window.
Statistical analyses
For all dependent variables, linear mixed modeling (LMM) was
applied with Subject as a random factor using SPSS version 23.
LMM was chosen in order to keep subjects in the analysis for
Fig. 1. Experimental setup with two participants seated next to each other be-
hind their own individual computer screens. Both participants performed the
task simultaneously while EEG was recorded.
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whom all conditions were not available on the assumption that
incomplete data were missing at random (Spronk et al., 2016).
Twelve cases (out of 96: 24 subjects 2 contexts 2 drug condi-
tions) were missing because of equipment failure (four cases) or
too few error trials (<6 errors). The averages of all included
cases were based on at least 11 trials.
The behavioral measures of interest were RT, the percentage
of erroneous responses, post-error slowing (PES; Rabbitt, 1966)
and post-error accuracy. PES was defined in a so-called robust
way that has been shown to be less sensitive to global perform-
ance fluctuations (Dutilh et al., 2012). PES robust is quantified as
a single-trial value of PES by comparing correct trials preceding
(pre-error) and following an error (post-error). Only error trials
that were both preceded and followed by at least one correct re-
sponse were included.
For the behavioral analyses, the possible fixed factors were
Substance (placebo, oxytocin), Context (individual, social),
Congruency (congruent, incongruent), Correctness (correct,
error) and PES (pre-error, post-error). The possible fixed factors
for the ERP analyses were the same, with the exception of PES
and the additional factor of Electrode (Fz, FCz, Cz for ERN, and
Fz, FCz, Cz, Pz for Pe). Significant interactions were further
investigated with follow-up analyses, which were adjusted for
multiple comparisons using Bonferroni corrections. Finally, bi-
variate correlation analyses were conducted to investigate
relationships between ERN amplitude on the one hand
and post-error adjustments (PES and post-error accuracy) on
the other.
Results
RTs and error rates
Mean RTs can be found in Table 1. The RT patterns were ana-
lyzed using two main analyses (cf. de Bruijn et al., 2004, 2006).
First, to investigate the effects of congruency, an analysis was
conducted on correct responses only. The main effect of
Substance was not significant (F< 1). As expected, the main ef-
fect of Congruency was significant with slower RTs for incon-
gruent (332 ms) compared with congruent trials (392 ms),
F(1,136.743)¼ 434.54, P< .001. The main effect of Context was
also significant, with overall slower RTs for the individual
(365 ms) than the social context (358 ms), F(1,136.988)¼ 7.12,
P¼ .009. None of the remaining two- or three-way interactions
were significant (all Fs< 1).
Second, to investigate the effect of correctness on RTs, an
analysis was conducted using incongruent trials only. Neither
the main effect of Substance (F< 1) nor the main effect of
Context, F(1,137.161)¼ 3.42, P¼ .066, reached significance. The
main effect of Correctness was significant, with faster RTs for
erroneous responses (289 ms) compared with correct ones
(392 ms), F(1,136.857)¼ 966.98, P< .001. The two-way inter-
actions (all Fs< 1) and three-way interaction, F(1,136.857)¼ 1.55,
P¼ .216, were not significant.
Mean error rates are given in Table 2. The error rate analyses
revealed a main effect of Congruency, with more errors made
on incongruent trials (26.6%) compared with congruent ones
(6.8%), F(1,136.134)¼ 322.32, P< .001. The main effect of Context
was near significant, F(1,137.143)¼ 3.69, P¼ .057, with numeric-
ally more errors made in the social (17.8%) compared with the
individual context (15.6%). The main effect of Substance was
not significant, F(1,140.718)¼ 2.13, P¼ .147) and neither were
any of the remaining two- or three-way interactions (all Fs< 1).
Adaptive behavior following errors
The main effect of PES was significant, F(1,136.59)¼ 25.49,
P< .001, with increased RTs for post-error responses (361 ms)
compared with pre-error responses (342 ms). None of the other
main effects or interactions was significant (all Fs< 1).
Bivariate correlations across all cases showed that PES did
not correlate significantly with ERN amplitude (r¼ .161,
P¼ .148), but that it did correlate significantly with post-error
accuracy (r¼ .22, P¼ .046), suggesting that PES provided time for
more task specific adjustments (cf. Danielmeier and Ullsperger,
2011; Fischer et al., 2015). In line with this, a significant positive
correlation between ERN amplitude and post-error accuracy
was also present, r¼ .472, P< .001.
To summarize, the behavioral analyses showed that RTs
were overall slower for the individual vs the social context,
while oxytocin did neither affect RTs nor error rates. Post-error
adjustment analyses showed that PES was present, but un-
affected by context or substance. Finally, larger ERN amplitudes
were overall associated with improved post-error accuracy.
Response-locked ERN analyses
Figure 2 depicts the mean ERN amplitudes for the different condi-
tions and the grand average waveforms are shown in Figures 3A
and 4A. As expected, the analyses on ERN amplitude demonstrated
a main effect for Correctness, F(1,459.803)¼ 778.39, P< .001, with
increased amplitudes for erroneous (11.97lV) compared with
Table 1. Mean reaction times in milliseconds for all conditions in both the individual and social context. Standard deviations are given in
parentheses
Placebo Oxytocin
Congruent Incongruent Congruent Incongruent
Correct Error Correct Error Correct Error Correct Error
Individual 334 (39) 324 (57) 394 (44) 286 (42) 339 (36) 317 (59) 399 (33) 300 (54)
Social 333 (41) 322 (72) 391 (48) 295 (50) 334 (45) 318 (75) 396 (45) 291 (39)
Table 2. Mean error percentages for all conditions in both the indi-
vidual and social context. Standard deviations are given in
parentheses
Placebo Oxytocin
Congruent Incongruent Congruent Incongruent
Individual 5.4 (3.7) 25.4 (13.2) 5.2 (3.9) 25.5 (12.0)
Social 6.3 (5.4) 25.7 (12.1) 7.7 (6.6) 27.1 (14.3)
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correct responses (1.38 lV). The main effect for Electrode was also
significant, F(2,459.688)¼ 6.87, P¼ .001. Neither the main effect of
Substance, F(1,472.361)¼ 1.52, P¼ .218), nor the main effect of
Context, F(1,462.336)¼ 1.27, P¼ .260) was significant. The inter-
action between Electrode and Correctness was significant,
F(2,459.688)¼ 7.91, P< .001, showing that the effect of Electrode
was significant for erroneous responses, F(2,459.688)¼ 14.73,
P< .001, but not for correct ones (F< 1). For errors, the amplitude
was maximal for FCz (13.76lV) compared with Fz (11.94lV,
F(1,138.508)¼ 6.78, P¼ .010) and Cz (10.21lV, F(1,139.156)¼ 25.06,
P< .001), reflecting the frontocentral distribution as depicted in
Figures 3B and 4B.
Importantly, the interactions between Substance and
Context, F(1,462.270)¼ 4.51, P¼ .034, and between Substance
and Correctness, F(1,459.803)¼ 5.14, P¼ .024, were significant.
These interactions were explained by the finding that the effect
of Substance was significant for the social context,
F(1,468.391)¼ 5.56, P¼ .019, but not for the individual one (F< 1)
and only for erroneous responses, F(1,466.775)¼ 6.11, P¼ .014,
not correct ones (F< 1). None of the remaining interactions were
significant (All Fs< 1.75, all Ps> .18).
To investigate the specificity of the effects of Substance and
Context on monitoring of errors further, we focused our ana-
lyses on erroneous responses only. The main effect of Electrode
remained significant, F(2,219.932)¼ 12.37, P< .001. Neither the
main effect of Substance, F(1,225.185)¼ 3.55, P¼ .061, nor the
main effect of Context was significant, F(1,220.854)¼ 1.62,
P¼ .205). Importantly, however, the interaction between
Substance and Context was significant, F(1,220.854)¼ 4.43,
P¼ .036, revealing increased ERN amplitudes in the social con-
























Fig. 2. Mean ERN amplitudes (in mV) of error trials for the placebo and oxytocin
condition in the individual and social context for electrodes Fz, FCz and Cz.
Error bars represent standard errors of the mean.
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Fig. 3. (A) Response-locked grand average waveforms for correct and incorrect responses in the individual and social context in the placebo condition for electrodes Fz,
FCz, Cz and Pz. (B) Topographical distributions of the difference waves (incorrect minus correct responses) collapsed over context for the ERN (peak onset at 78 ms,
top), the early Pe (peak onset at 229 ms, middle) and for the late Pe (mean amplitude in 300–500 ms time window, bottom).
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administration (10.99 lV, F(1,223.395)¼ 7.83, P¼ .006). ERN amp-
litudes did not differ significantly between the oxytocin
(11.39 lV) and placebo (11.48 lV) condition for the individual
context (F< 1). Please note that similar patterns and outcomes
were observed when including order of the sessions as an add-
itional factor and when not the peak-to-peak measure of the
ERN, but only the most negative peak in the 0–150 ms time win-
dow following response onset was taken as a measure of ERN
amplitude (see Supplementary Material for details).
Response-locked Pe analyses
The analyses on early Pe amplitudes showed a main effect of
Correctness, F(1,617.18)¼ 319.94, P< .001, with increased ampli-
tudes for incorrect (12.29 mV) compared with correct responses
(6.04 mV). The main effect of Electrode, F(1,617.18)¼ 13.78,
P< .001, and the significant interaction between Correctness
and Electrode, F(3,617.18)¼ 4.26, P¼ .005, revealed the fronto-
central topographical distribution of the component (see
Figures 3B and 4B). Amplitudes were maximal for erroneous re-
sponses at FCz (14.71 mV) and Cz (12.94mV) compared with Fz
(10.55mV; Ps< .005) and Pz (10.94 mV; Ps< .027). None of the re-
maining main effects or interactions was significant (all
Fs< 2.35, all Ps> .125).
The analyses on late Pe amplitudes demonstrated a main ef-
fect of Correctness, F(1,617.495)¼ 331.14, P< .001, with increased
amplitudes for incorrect (3.84 lV) compared with correct
responses (2.06 lV). Significant effects were also present
for Electrode, F(3,617.495)¼ 34.20, P< .001, and Substance,
F(1,630.281)¼ 3.96, P¼ .047. The interactions between Substance
and Context, F(1,620.415)¼ 5.81, P¼ .016, and between
Correctness and Electrode, F(3,617.495)¼ 17.03, P< .001, were
significant. Pairwise comparisons for the first interaction dem-
onstrated that the effect of Context was not significant for the
oxytocin condition (F< 1), but limited to placebo administration,
F(1,620.280)¼ 8.71, P¼ .003, with decreased amplitudes in the so-
cial context (.10 lV) compared with the individual one
(1.22 lV). The three-way interaction between Substance,
Context and Correctness was not significant, F(1,617.495)¼ 3.47,
P¼ .063.
Discussion
The aim of the current study was to investigate the effects of
oxytocin on individual vs social mistakes by analyzing
performance-related ERP components. With the exception of
slower correct response times in the individual compared with
the social context, behavior was neither modulated by oxytocin
Oxytocin condition
Cz Pz


























































Fig. 4. (A) Response-locked grand average waveforms for correct and incorrect responses in the individual and social context in the oxytocin condition for electrodes
Fz, FCz, Cz and Pz. (B) Topographical distributions of the difference waves (incorrect minus correct responses) collapsed over context for the ERN (peak onset at 85 ms,
top), the early Pe (peak onset at 236 ms, middle) and for the late Pe (mean amplitude in 300–500 ms time window, bottom).
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nor by the social context. At the electrophysiological level, fol-
lowing oxytocin administration, ERN amplitudes were
increased for social compared with individual mistakes. After
placebo, reduced (late) Pe amplitudes were present for the social
compared with the individual context, but ERN amplitudes did
not differ between individual or social mistakes.
As participants were seated next to each other both in the
individual and the social context, the overall slower RTs in the
individual context cannot be simply explained by social facilita-
tion, i.e. the idea that people in general perform better or faster
on simple tasks in the presence of other people (Zajonc, 1965).
The slower responses may, however, result from an absence of
direct performance feedback. Consequently, participants were
unsure how well their co-actor was performing and this may
have resulted in a tendency to speed up compared with the in-
dividual setting. The numerically higher error rate in the social
context may also be seen as indicative of the presence of a
speed-accuracy tradeoff of in the social compared with the indi-
vidual setting. Previous studies have shown that performance
differences, such as dissimilar error rates, may affect the ampli-
tude of the ERN (see e.g. Fischer et al., in press; Gehring et al.,
1993). The currently observed absence of behavioral drug effects
thus ensures that the present ERP findings are not confounded
by such differences in performance.
In line with our hypotheses, oxytocin increased ERN ampli-
tudes specifically for social compared with individual mistakes.
This outcome shows that, under the influence of oxytocin,
knowing that one’s actions may negatively affect another per-
son results in stronger error-related activations in the brain.
Enhancements in performance monitoring have previously
been associated with increased error significance or affective
distress in an online evaluation task (Hajcak et al., 2005). It is
plausible that similar mechanisms are at work for mistakes that
additionally affect a co-actor in a negative manner, for example
through enhanced feelings of responsibility in the social con-
text. In line with this, there is an abundance of clinical work on
(non-social) performance monitoring, showing that OCD is
related to excessive error-related brain responses (Endrass and
Ullsperger, 2014). Interestingly, one of the major symptoms of
patients suffering from OCD is inflated responsibility and a fear
of making mistakes that will negatively affect other people
(Hezel and McNally, 2016). Hence, the current outcomes may
have important clinical implications. Although studies using
animal models have suggested a close link between oxytocin
and compulsive behavior such as hypergrooming in rats
(Marroni et al., 2007), the few studies that investigated effects of
intranasal oxytocin in patients with OCD did not demonstrate
clear effects on obsessive–compulsive symptoms (see e.g. den
Boer and Westenberg, 1992; Epperson et al., 1996). On the con-
trary, one case study that did demonstrate improvement during
4 weeks of treatment (Ansseau et al., 1987) also reported unex-
pected but serious side effects such as the development of
psychotic symptoms. The latter supports the idea that caution
in using oxytocin in OCD treatment is warranted and that more
research is needed. Future studies should therefore focus on
whether OCD patients show a similar excessive response to so-
cial mistakes and whether oxytocin administration may thus
even result in adverse effects on social performance-monitoring
processes in these patients.
The finding of enhanced performance monitoring of social
mistakes after oxytocin administration is in line with the idea
that oxytocin may increase the salience of social cues (see e.g.
Nave, Camerer and McCullough, 2015; Burkett and Young, 2012;
Gordon et al., 2011; Quattrocki and Friston, 2014) and that some
social-behavioral effects may result from its impact on motiv-
ational networks (Love, 2014). The central idea of the recently
proposed social salience theory of oxytocin (Shamay-Tsoory
and Abu-Akel, 2016) is that the hormone facilitates attention-
orienting to external contextual social cues, but that effects
may be baseline dependent. Our data therefore suggest that
oxytocin may increase the salience of mistakes, specifically in a
social context. The current outcomes also show that this is not
simply the result of a general increase in attention, as there
were no substance or context effects on relevant attentional
stimulus-locked ERP components (see Supplementary Material).
The neurotransmitter dopamine is known to play a pri-
mary role in salience attribution and has therefore been
thought to be involved in oxytocin-induced effects of social sa-
lience (Shamay-Tsoory and Abu-Akel, 2016). This assumption
is based on the fact that oxytocin’s receptors are located
throughout the mesocorticolimbic dopamine system (Love,
2014). Also, animal studies have demonstrated a direct influ-
ence of oxytocin on dopamine release (Sanna et al., 2012;
Shahrokh et al., 2010). Notably, dopamine has also been pro-
posed to play a central role in performance monitoring. The
reinforcement-learning theory of performance monitoring
(Holroyd and Coles, 2002) posits that whenever an outcome is
worse than expected (i.e. an error) a temporarily decrease in
dopamine release occurs. This prediction error signal (see e.g.
Schultz, 2016a,b) may importantly generate the ERN and sub-
sequent behavioral changes. Support for the involvement of
dopamine in performance monitoring in non-social contexts
comes from studies from our own and other labs showing that
increasing levels of dopamine through administering com-
pounds that act as indirect dopamine agonists results in
increased ERN amplitudes (see e.g. de Bruijn et al., 2004), while
the reverse occurs for indirect dopamine antagonists (see e.g.
de Bruijn et al., 2006; Zirnheld et al., 2006).
More recently, Quattrocki and Friston (2014) have high-
lighted that both dopamine and oxytocin have specific and tar-
geted effects on the cingulate-insula network. In their review,
the authors propose a central role for the oxytocin system in
interoception, i.e. the process of sensing the internal state of
the body. Crucially, they postulate that the cingulate-insula
network not only modulates proprioceptive signals allowing for
flexible motor control, but that it also controls autonomic proc-
esses through updating of expectations about our emotional
and embodied self through interoceptive predictions. While the
first process is assumed to rely on dopamine function and may
thus explain the effects dopamine has on performance moni-
toring, oxytocin may be similarly involved by regulating
homeostasis through minimizing interoceptive prediction
errors. We propose that, during performance monitoring, such
prediction errors may result from the distress and averseness
associated with social mistakes. The current findings seem
thus to be more in line with a relative direct effect of oxytocin
on performance monitoring rather than an indirect effect
through oxytocin-induced dopamine release. On the basis of
the outcomes of existing pharmacological performance-
monitoring studies, one would actually expect such indirect ef-
fect of dopamine release to affect performance monitoring in a
more general manner, i.e. increases in both the individual and
social context. The present study therefore suggests that the ef-
fects of oxytocin on performance monitoring are context
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dependent with specific enhancements in the social context
only. Future studies should aim at unraveling the complex
interplay of these fundamental processes and oxytocin-
dopamine interactions further.
The finding that ERN amplitudes were not increased for so-
cial compared with individual mistakes in the placebo condition
was unexpected, but may be related to the indirect nature of the
manipulation. To keep the comparisons as clean as possible,
the two contexts were identical and only the instructions varied
between the individual and the social setting. As a result, the
manipulation of error consequences remained subtle and might
thus not have had the required impact to affect performance
monitoring in the placebo condition. In contrast to previous
fMRI studies (Radke et al., 2011; Koban et al., 2013), for example,
committed errors in the current study were not visible to the
co-actor and also the consequences of an error were delayed
until after the study ended.
Interestingly, however, an effect of context did occur in the
placebo condition for the (late) Pe, with decreased amplitudes in
the social setting. The Pe has often been associated with con-
scious error awareness (Overbeek et al., 2005) and the motiv-
ational salience of errors (Ridderinkhof et al., 2009). The reduced
Pe in the social context may thus reflect a diminished emotional
response to possible errors. Accordingly, this outcome reveals a
reversed pattern of the one seen in the oxytocin condition, with
a reduced impact on performance monitoring in the social rather
than the individual context. Although we remain cautious in
interpreting this unexpected finding in a post-hoc manner, pos-
sible explanations may be found in theories of social psychology
focusing on diffusion of responsibility and social loafing (see
e.g. Gilovich et al., 2005; Karau and Williams, 1993; Latané et al.,
1979). Both participants performed the task simultaneously and
were aware that the other person is likely to make mistakes as
well and will thus also negatively affect the chance of winning a
joint prize. Unlike the oxytocin condition, following placebo this
knowledge seems to result in a decrease of personal account-
ability in the social compared with the individual context.
It would be interesting to see whether future studies could shed
more light on this by focusing on (i) a possible relationship be-
tween decreased personal accountability and later—more con-
scious and emotional—performance-monitoring processes as
reflected in the Pe and (ii) the possible role of oxytocin in re-
sponsibility alterations in social performance monitoring.
Although there are many practical reasons for not including
female participants in an oxytocin administration study, such
as issues related to menstrual cycle, the inclusion of only male
participants can be considered a limitation and may prevent
generalizations across genders. Compared with other pharma-
cological performance-monitoring studies (see e.g. de Bruijn
et al., 2004, 2006; Riba et al., 2005; Spronk et al., 2014), the current
sample size of 24 participants in a within-subjects design with
repeated measures is relatively large. However, we would like to
emphasize that the present findings are in need of replication
preferably in a larger sample size that also includes female par-
ticipants (see Walum et al., 2016). Another limitation of the cur-
rent study is the use of delayed feedback. Although this had the
major advantage of keeping the two contexts as similar as pos-
sible, this may have reduced the impact of the social mistakes,
especially in the placebo setting. Future studies should there-
fore increase the immediate impact of errors in the social
context.
The current study did not reveal a behavioral equivalent of
increased social performance monitoring after oxytocin admin-
istration. However, the finding of a drug-induced ERN effect in
the absence of an effect on PES is quite common. Almost all pre-
vious pharmacological performance-monitoring studies have
demonstrated this pattern, thus ERN effects in the absence of
effects on PES (e.g. de Bruijn et al., 2004, 2006; Riba et al., 2005;
Spronk et al., 2014; Zirnheld et al., 2006). Even in studies with
larger sample sizes, e.g. because of an additional focus on indi-
vidual differences, no drug effects on post-error behavior were
found (Barnes et al., 2014; Spronk et al., 2016). The current
method may thus not be sensitive enough to investigate this
specific issue also because several factors are known to modu-
late PES. Specifically, although behavioral measures such as
overall performance, general RTs, and PES can be derived from
the Flankers paradigm, a fine balance between instructions,
task details, and these measures exists. For example, the gen-
eral instruction that equally emphasizes speed and accuracy
may limit the occurrence of PES (Danielmeier and Ullsperger,
2011) and a recent study in a large sample size showed that
males display less PES than females (Fischer et al., 2016). Also, in
pharmacological ERP studies one general aim is to keep per-
formance as similar as possible between the different condi-
tions. This enables drawing conclusions about the ERP findings
without possible confounds of behavioral effects. A side effect
of this may be that it limits the occurrence and variance of be-
havioral measures of interest.
The only support for a relationship between performance
monitoring and post-error adjustments was reflected in the
positive correlation between post-error accuracy and ERN amp-
litude across all cases. This finding, which was previously
shown by Carp and Compton (2009), suggests that independent
of context and substance enhanced performance monitoring
was associated with increased performance following errors.
We would like to emphasize, however, that the current data did
not provide direct evidence that this finding is indicative of im-
proved task-specific adjustments following social mistakes
after oxytocin administration. On the contrary, one might also
argue that increased responsiveness to social mistakes may ac-
tually lead to worse performance resulting from a lapse of at-
tention due to the distress associated with the error and
resulting re-orienting process. Dedicated studies that, for ex-
ample additionally examine the coupling between ERN ampli-
tude and post-error adjustments (see e.g. Fischer et al., 2015,
2016) may be able to shed more light on the question if and how
enhanced social performance monitoring following oxytocin is
reflected in behavior.
To summarize, the present study is the first to demonstrate
acute effects of oxytocin on performance monitoring. This cen-
tral process enables humans to perform in a flexible and safe
manner, not only in individual but also in social contexts.
The results showed an oxytocin-induced enhancement of per-
formance monitoring specifically for social mistakes, which
was not present in the placebo condition. These outcomes are
in line with recent theories that propose a central role for oxyto-
cin in salience attribution to social cues. Moreover, dopamine
has been argued to play a crucial role in both oxytocin-induced
salience attribution and performance monitoring, which add-
itionally emphasizes the clinical relevance of the combined re-
search topics. Performance monitoring deficits have been
reported in many psychiatric disorders and especially anxiety
disorders are associated with excessive responses to mistakes.
Bringing together these two relevant research domains may
thus importantly open up new research avenues and improve
our understanding of individual differences in performance
monitoring and oxytocin responses from a social neurocogni-
tive, a pharmacological, as well as a clinical perspective.
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